News Headlines Article

Big Pharma spinout on Peninsula targets childhood liver diseases, $86M IPO
San Francisco Business Times

Mike Grey four years ago sold his Lumena Pharmaceuticals Inc. — including two drugs targeting liver diseases — to Shire plc. On Friday, his new Peninsula company filed for an $86.25 million initial public offering to take those same two drugs deeper into the clinical trials.

Mirum Pharmaceuticals Inc., a 24-employee company in Foster City, said in a Securities and Exchange Commission filing that it expects to use the money to complete a late-stage clinical trial of the drug marlixibat and start and finish a mid-stage study of volixibat.